Biogen Sees Interest In Potential Biosimilars Deal
Biosimilars Turnover Steady In Q2; Also Provides Update On Tysabri And Tecfidera Rivals
• By David Wallace
Biogen is “engaged with multiple interested parties” over a potential biosimilars sale • Source: Shutterstock 
